首页 > 市场调查报告书 > 医疗设备

眼科设备

市场调查报告书

商品编码

1665193

眼部植入物市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Ocular Implants Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2024年12月14日 | 出版商:

Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024 年全球眼部植入物市场价值为 171 亿美元，预计在 2025 年至 2034 年期间实现 6.4% 的复合年增长率。此外，青光眼和白内障等慢性眼部疾病的激增，以及人们对视力矫正治疗认识的提高，进一步推动了眼部植入物的采用。植入材料和设计的技术创新也促进了市场的成长，确保了更好的患者治疗效果和更高的安全性。

市场分为青光眼植入物、人工水晶体、眼眶植入物、眼部假体和其他相关产品。其中，青光眼植入物领域脱颖而出，预计到 2034 年将实现 6.2% 的复合年增长率，达到 121 亿美元。这一增长主要是由于青光眼患病率上升，尤其是在老年人群中，凸显了对管理眼压 (IOP) 的有效解决方案的需求日益增加。因此，青光眼植入物正在成为改善患者生活品质、提供更好的眼压控制和减少併发症的关键组成部分。

市场范围
起始年份	2024
预测年份	2025-2034
起始值	171亿美元
预测值	311亿美元
复合年增长率	6.4%

从应用角度来看，眼部植入物市场细分为老年黄斑部病变、青光眼手术、药物传输、眼整形和美容目的。 2024 年青光眼手术市场价值为 63 亿美元，预计到 2034 年复合年增长率将达到 6.7%。这些创新提高了安全性、生物相容性和整体治疗效果，使其在患者和医疗保健提供者中更受欢迎。

2024 年美国眼部植入物市场价值为 64 亿美元，预计 2025-2034 年期间的复合年增长率为 6.1%。该国人口众多且老化，患有各种与年龄相关的眼部疾病，包括白内障、青光眼、糖尿病视网膜病变和黄斑部病变。随着老龄人口不断增长和慢性眼疾发病率上升，用于矫正视力和管理高眼压的先进眼部植入物的需求持续增加。需求的激增推动了美国市场的大幅成长，医疗保健的进步在满足患者不断变化的需求方面发挥着至关重要的作用。

产业生态系统分析
产业衝击力
- 成长动力
  - 眼部疾病盛行率不断上升
  - 人工水晶体设计的创新
  - 眼科手术激增
- 产业陷阱与挑战
  - 植入物和手术费用高昂
  - 严格的监管要求
成长潜力分析
监管格局
技术格局
差距分析
波特的分析
PESTEL 分析
价值链分析
未来市场趋势

第四章：竞争格局

介绍
公司市占率分析
主要市场参与者的竞争分析
竞争定位矩阵
策略仪表板

第 5 章：市场估计与预测：按产品，2021 年至 2034 年

主要趋势
青光眼植入物
人工水晶体
眼眶植入物
义眼
其他产品

第 6 章：市场估计与预测：按应用，2021 年至 2034 年

主要趋势
青光眼手术
眼整形手术
药物输送
老年性黄斑部病变
美学目的

第 7 章：市场估计与预测：依最终用途，2021 年至 2034 年

主要趋势
医院
眼科诊所
其他最终用户

第 8 章：市场估计与预测：按地区，2021 年至 2034 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋

第九章：公司简介

AbbVie
Alcon
Bausch Health
Glaukos Corporation
Gulden Ophthalmics
HOYA Corporation
HumanOptics Holding
Johnson & Johnson
Lenstec
MORCHER
NIDEK
Orbtex
Rayner Group
STAAR Surgical
ZEISS Group

简介目录

Product Code: 12672

The Global Ocular Implants Market, valued at USD 17.1 billion in 2024, is set for robust growth at a CAGR of 6.4% from 2025 to 2034. This impressive expansion is fueled by multiple factors, including the increasing demand for aesthetic enhancements, the rising popularity of minimally invasive procedures, escalating healthcare spending, and a growing aging population in need of advanced eye care solutions. Additionally, the surge in chronic eye diseases, such as glaucoma and cataracts, along with rising awareness about vision correction treatments, is further driving the adoption of ocular implants. Technological innovations in implant materials and designs also contribute to the market's growth, ensuring better patient outcomes and increased safety.

The market is categorized into glaucoma implants, intraocular lenses, orbital implants, ocular prostheses, and other related products. Among these, the glaucoma implants segment stands out, expected to achieve a CAGR of 6.2% and reach USD 12.1 billion by 2034. This growth is primarily driven by the rising prevalence of glaucoma, especially among older populations, highlighting the increasing demand for effective solutions to manage intraocular pressure (IOP). As a result, glaucoma implants are becoming a critical component in improving the quality of life for patients, offering better IOP control and fewer complications.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$17.1 Billion
Forecast Value	$31.1 Billion
CAGR	6.4%

Focusing on applications, the ocular implants market is segmented into age-related macular degeneration, glaucoma surgery, drug delivery, oculoplasty, and aesthetic purposes. The glaucoma surgery segment, valued at USD 6.3 billion in 2024, is expected to grow at a CAGR of 6.7% by 2034. The demand for glaucoma implants is driven by advancements in implant design, which include smaller, more effective, and minimally invasive options. These innovations enhance safety, biocompatibility, and overall treatment effectiveness, making them more popular among both patients and healthcare providers.

The U.S. ocular implants market, valued at USD 6.4 billion in 2024, is projected to grow at a CAGR of 6.1% during 2025-2034. The country has a large and aging population dealing with various age-related eye conditions, including cataracts, glaucoma, diabetic retinopathy, and macular degeneration. As the elderly population continues to grow and the incidence of chronic eye diseases rises, the demand for advanced ocular implants to address vision correction and manage high intraocular pressure continues to increase. This surge in demand is driving significant growth in the U.S. market, with healthcare advancements playing a crucial role in meeting the evolving needs of patients.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of eye disorders
  - 3.2.1.2 Innovations in intraocular lens design
  - 3.2.1.3 Surge in ophthalmic surgeries
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of implants and procedures
  - 3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Gap analysis
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Value chain analysis
3.10 Future market trends

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

5.1 Key trends
5.2 Glaucoma implants
5.3 Intraocular lenses
5.4 Orbital implants
5.5 Ocular prosthesis
5.6 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

6.1 Key trends
6.2 Glaucoma surgery
6.3 Oculoplasty
6.4 Drug delivery
6.5 Age-related macular degeneration
6.6 Aesthetic purpose

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Ophthalmic clinics
7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE